Nuwellis, Inc.

XNASHealth care

Last traded price · USD

$5.18

−1.71%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:30 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $5.27
Volume: 16
Day's high: —
Day's low: —

In brief

Nuwellis, Inc. is a health care company listed on Nasdaq, valued at about $2M.
Its shares closed at $5.27 on 4 Nov 2026, down 99.4% over the past year.
From India you can buy NUWE in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Nuwellis, Inc. (NUWE) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole NUWE share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade NUWE options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: −16.5% (SPY −1.6%, XLV +13.5%). 3 months: −65.8% (SPY −0.4%, XLV +15.5%). 1 year: −99.4% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: NUWE, SPY and XLV · as of 4 Nov 2026
108.8% above its 52-week low
Closed at $5.27 on 4 Nov 2026: 99.7% below the 52-week high of $1,556.07 (27 Jan 2026) and 108.8% above the low of $2.52 (26 Oct 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $5.27 was 17.6% below its 50-day average ($6.40) and 97.7% below its 200-day average ($228.98). It has closed below the 200-day for 1045 sessions, since 7 Sep 2022.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
89.4K shares sold short
89.4K shares were sold short at the 15 Oct 2026 settlement; covering them would take 1.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−16.5%

6 months−98.5%

1 year−99.4%

5 years−100.0%

Newswire

About

Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Website

Notable moves

July 30, 2026
+135.45%
July 16, 2025
+131.33%
August 31, 2022
+131.71%

Nuwellis, Inc.

XNASHealth care

Last traded price · USD

$5.18

−1.71%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:30 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $5.27
Volume: 16
Day's high: —
Day's low: —

In brief

Nuwellis, Inc. is a health care company listed on Nasdaq, valued at about $2M.
Its shares closed at $5.27 on 4 Nov 2026, down 99.4% over the past year.
From India you can buy NUWE in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Nuwellis, Inc. (NUWE) shares from India?

Do I need the price of a whole NUWE share to invest?

How much can I invest in US stocks in a year?

Can I trade NUWE options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: −16.5% (SPY −1.6%, XLV +13.5%). 3 months: −65.8% (SPY −0.4%, XLV +15.5%). 1 year: −99.4% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: NUWE, SPY and XLV · as of 4 Nov 2026
108.8% above its 52-week low
Closed at $5.27 on 4 Nov 2026: 99.7% below the 52-week high of $1,556.07 (27 Jan 2026) and 108.8% above the low of $2.52 (26 Oct 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $5.27 was 17.6% below its 50-day average ($6.40) and 97.7% below its 200-day average ($228.98). It has closed below the 200-day for 1045 sessions, since 7 Sep 2022.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
89.4K shares sold short
89.4K shares were sold short at the 15 Oct 2026 settlement; covering them would take 1.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−16.5%

6 months−98.5%

1 year−99.4%

5 years−100.0%

Newswire

About

Website

Notable moves

July 30, 2026
+135.45%
July 16, 2025
+131.33%
August 31, 2022
+131.71%

Nuwellis, Inc.

Nuwellis, Inc. in brief

Behind SPY and its sector fund XLV over 1 year

108.8% above its 52-week low

Below its 50- and 200-day averages

89.4K shares sold short

Nuwellis, Inc.

Nuwellis, Inc. in brief

Behind SPY and its sector fund XLV over 1 year

108.8% above its 52-week low

Below its 50- and 200-day averages

89.4K shares sold short